Lauren Constantini

Lauren Constantini is currently an Advisor at Boomtown Accelerators. Prior to that, they were the Head of Operations at Neuraptive Therapeutics from January 2019 to August 2020. There, they oversaw all operations to bring a drug/device combination product for peripheral nerve injury from early development to Phase II clinical trials.

From April 2012 to May 2014, Ms. Constantini was the Vice President of Therapeutics and Device Development at the Colorado Institute for Drug, Device and Diagnostic Development (CID4). In that role, they managed CID4's activities of analyzing, funding and managing emerging life science technologies and moving them towards commercial success.

Ms. Constantini was also the President and CEO of Prima-Temp Inc. from July 2013 to December 2017. At Prima-Temp, they brought a groundbreaking wearable sensor that tracks continuous core body temperature for early recognition of ovulation and acute illness from prototype to launch. Lauren raised 3 rounds of funding and lead a team of engineers, marketers, and clinical regulatory members.

From September 2009 to September 2014, Ms. Constantini served as a consultant Vice President Product Management for FluTrends International.

Lauren Constantini has a post-doctoral degree in neuroregeneration from Harvard Medical School. Lauren also has a PhD in neuroscience/biomedical science from Albany Medical College. Lauren Constantini also has a BS in biology/chemistry with a dance minor from Purchase College. Lauren is also certified in nutrition science from Stanford Center for Health Education.